Novel 11β-alkyl steroids of the estrane series
Abstract
Abstract The present invention relates to novel steroids of the estrane series having the general formula I: ##SPC1## wherein R 1 and R 2 = an alkyl group having 1-4 carbon atoms, R 3 = oxygen or (αP)(βQ), wherein P = hydrogen or a saturated or an unsaturated alkyl group having 1-4 carbon atoms, and Q = a free, esterified or etherified hydroxyl group, and A double bond is present departing from carbon atom 5, and to the preparation thereof. The compounds according to the invention possess very valuable anabolic, androgenic, estrogenic, anti-estrogenic, progestative, anti-progestative, ovulation-inhibiting and gonad-inhibiting properties and are furthermore of value owing to their peripheral anti-fertility activity.
Inventors
- 👤 Johannes Antonius Joseph Leemhuis
Bibliographic Details
Claims Analysis
Total Claims: 8References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-09-28 | 1980-03-29 | 1980-09-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-09-28 | 1984-03-29 | 1984-09-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-09-28 | 1988-03-29 | 1988-09-28 | $7700.00 | Window Closed / Lapsed |